From November 9, 2023 to December 31, 2023, the company has repurchased 5,560,189 shares, representing 2.3% for $500 million. With this, the company has completed the repurchase of 5,560,189 shares, representing 2.3% for $500 million under the buyback announced on November 9, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.86 USD | -0.32% | -0.55% | +6.17% |
05-06 | Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6% | MT |
05-03 | JPMorgan Adjusts Price Target on Hologic to $91 From $85 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.17% | 17.7B | |
+8.07% | 219B | |
+7.87% | 185B | |
+12.75% | 135B | |
-1.37% | 62.21B | |
+4.88% | 51.01B | |
+11.59% | 51.28B | |
+2.71% | 41.85B | |
+4.90% | 37.02B | |
+23.75% | 31.27B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Tranche Update on Hologic, Inc.'s Equity Buyback Plan announced on November 9, 2023.